Distinct modulatory effects of LPS and CpG on IL-18-dependent IFN-gamma synthesis

J Immunol. 2004 Feb 1;172(3):1754-62. doi: 10.4049/jimmunol.172.3.1754.

Abstract

Innate cellular production of IFN-gamma is suppressed after repeated exposure to LPS, whereas CpG-containing DNA potentiates IFN-gamma production. We compared the modulatory effects of LPS and CpG on specific cellular and cytokine responses necessary for NK-cell dependent IFN-gamma synthesis. C3H/HeN mice pretreated with LPS for 2 days generated 5-fold less circulating IL-12 p70 and IFN-gamma in response to subsequent LPS challenge than did challenged control mice. In contrast, CpG-pretreated mice produced 10-fold more circulating IFN-gamma without similar changes in IL-12 p70 levels, but with 10-fold increases in serum IL-18 relative to LPS-challenged control or endotoxin-tolerant mice. The role of IL-18 in CpG-induced immune potentiation was studied in splenocyte cultures from control, LPS-conditioned, or CpG-conditioned mice. These cultures produced similar amounts of IFN-gamma in response to rIL-12 and rIL-18. However, only CpG-conditioned cells produced IFN-gamma when cultured with LPS or CpG, and production was ablated in the presence of anti-IL-18R Ab. Anti-IL-18R Ab also reduced in vivo IFN-gamma production by >2-fold in CpG-pretreated mice. Finally, combined pretreatment of mice with LPS and CpG suppressed the production of circulating IFN-gamma, IL-12 p70, and IL-18 after subsequent LPS challenge. We conclude that CpG potentiates innate IFN-gamma production from NK cells by increasing IL-18 availability, but that the suppressive effects of LPS on innate cellular immunity dominate during combined LPS and CpG pretreatment. Multiple Toll-like receptor engagement in vivo during infection can result in functional polarization of innate immunity dominated by a specific Toll-like receptor response.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Adjuvants, Immunologic / blood
  • Animals
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • Cell Survival / immunology
  • Cells, Cultured
  • CpG Islands / immunology*
  • Dendritic Cells / immunology
  • Drug Synergism
  • Female
  • Immunity, Cellular
  • Immunization, Secondary
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / blood
  • Interferon-gamma / biosynthesis*
  • Interferon-gamma / blood
  • Interleukin-18 / biosynthesis
  • Interleukin-18 / blood
  • Interleukin-18 / physiology*
  • Interleukin-18 Receptor alpha Subunit
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Lipopolysaccharides / administration & dosage*
  • Lipopolysaccharides / blood
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred C57BL
  • Oligodeoxyribonucleotides / administration & dosage*
  • Oligodeoxyribonucleotides / immunology
  • Receptors, Interleukin / biosynthesis
  • Receptors, Interleukin-18
  • Spleen / cytology
  • Spleen / immunology
  • Spleen / metabolism
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Vaccines, DNA / administration & dosage
  • Vaccines, DNA / immunology

Substances

  • Adjuvants, Immunologic
  • CPG-oligonucleotide
  • Il18r1 protein, mouse
  • Immunosuppressive Agents
  • Interleukin-18
  • Interleukin-18 Receptor alpha Subunit
  • Lipopolysaccharides
  • Oligodeoxyribonucleotides
  • Receptors, Interleukin
  • Receptors, Interleukin-18
  • Vaccines, DNA
  • Interferon-gamma